Glove shortages loom as recalls spike and M&A reshapes
Supply Chain Pulse — 2026-05-05
Global glove manufacturers are warning of raw material shortages and price hikes that could hit hospital inventories within months, just as InspireMD issues another voluntary recall for its CGuard Prime carotid stent system. Meanwhile, Masimo shareholders greenlit a $9.9B acquisition by Danaher, marking the latest in a wave of healthcare consolidation that's reshaping vendor relationships across supply chains. It's shaping up to be a stress-test quarter for procurement teams juggling commodity inflation, device recalls, and shifting supplier landscapes.
Quick Hits
- Hospital systems increasingly partner with home health companies for operational management (Modern Healthcare)
- Nemours Children's Hospital elevates sterile processing as strategic asset with tech investments (Healthcare Purchasing News)
- CSX reports volume growth from truck-to-rail conversions amid rising fuel costs (Supply Chain Dive - Healthcare)
- Cleveland Clinic and OhioHealth help design Hippocratic AI's Nurse Co-Pilot tool (Modern Healthcare)
- AI imaging company Aidoc raises $150M, bringing total funding over $500M (Modern Healthcare)
Global glove supply faces raw material crunch, price surge ahead
Glove manufacturers worldwide are grappling with raw material shortages and escalating costs that threaten to disrupt hospital supplies in coming months. While most facilities maintain buffer inventories from pandemic stockpiling, sustained disruptions could force procurement teams to absorb significant price increases or face shortages of this critical PPE category.
Source: Healthcare Purchasing News
Masimo shareholders approve $9.9B Danaher acquisition
The deal consolidates another major medical device manufacturer under Danaher's portfolio, potentially impacting pricing and contract negotiations for hospitals using Masimo's patient monitoring systems. Supply chain teams should prepare for possible vendor relationship changes and contract transitions as the acquisition closes later this year.
InspireMD recalls CGuard Prime carotid stent delivery system
The voluntary recall of the CGuard Prime 135cm carotid stent delivery system adds to growing device recall volumes that supply chain teams must track and manage. Facilities using this product should immediately check inventory and coordinate with clinical teams on alternative options for carotid interventions.
Source: Medical Device Network
AbbVie commits $1.4B to North Carolina manufacturing campus
The 185-acre facility will focus on small-volume parenteral products including vials and prefilled syringes, potentially improving domestic supply chain resilience for these critical drug delivery formats. The investment signals continued reshoring efforts that could reduce import dependencies for hospital pharmacies.
Source: Supply Chain Dive - Healthcare
ECRI spins out spend and recall management into new company Staritas
The separation of ECRI's spend management and recall tracking services into standalone company Staritas could impact contract terms and service delivery for hospitals relying on these supply chain solutions. Procurement teams should monitor transition plans and ensure continuity of recall monitoring capabilities.
Source: Healthcare Purchasing News
UPMC to acquire CommonSpirit's Trinity Health operations
The acquisition will create new opportunities for supply chain consolidation and potentially stronger vendor negotiations through increased purchasing volume. Regional suppliers and GPO relationships may shift as UPMC integrates Trinity Health's procurement operations this fall.
Atrium Health plans $2B WakeMed merger and expansion
The merger includes a substantial $2B facility investment that will drive significant capital equipment and construction supply opportunities in North Carolina. Supply chain teams at both organizations should prepare for integration planning and potential vendor rationalization efforts.
Olympus secures global distribution for EndoRobotics technology
The exclusive partnership expands Olympus's EndoTherapy portfolio with robot-assisted technologies, potentially creating new capital equipment considerations for surgical services. ASCs and hospitals planning robotic surgery investments should evaluate these emerging options alongside established platforms.
Source: Medical Device Network
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe